277 related articles for article (PubMed ID: 17962340)
1. Na(+) -glucose transporter-2 messenger ribonucleic acid expression in kidney of diabetic rats correlates with glycemic levels: involvement of hepatocyte nuclear factor-1alpha expression and activity.
Freitas HS; Anhê GF; Melo KF; Okamoto MM; Oliveira-Souza M; Bordin S; Machado UF
Endocrinology; 2008 Feb; 149(2):717-24. PubMed ID: 17962340
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte nuclear factors 1α/4α and forkhead box A2 regulate the solute carrier 2A2 (Slc2a2) gene expression in the liver and kidney of diabetic rats.
David-Silva A; Freitas HS; Okamoto MM; Sabino-Silva R; Schaan BD; Machado UF
Life Sci; 2013 Nov; 93(22):805-13. PubMed ID: 24157454
[TBL] [Abstract][Full Text] [Related]
3. High Basolateral Glucose Increases Sodium-Glucose Cotransporter 2 and Reduces Sirtuin-1 in Renal Tubules through Glucose Transporter-2 Detection.
Umino H; Hasegawa K; Minakuchi H; Muraoka H; Kawaguchi T; Kanda T; Tokuyama H; Wakino S; Itoh H
Sci Rep; 2018 May; 8(1):6791. PubMed ID: 29717156
[TBL] [Abstract][Full Text] [Related]
4. SLC2A2 gene expression in kidney of diabetic rats is regulated by HNF-1alpha and HNF-3beta.
Freitas HS; Schaan BD; David-Silva A; Sabino-Silva R; Okamoto MM; Alves-Wagner AB; Mori RC; Machado UF
Mol Cell Endocrinol; 2009 Jun; 305(1-2):63-70. PubMed ID: 19433262
[TBL] [Abstract][Full Text] [Related]
5. Effect of phlorizin on SGLT2 expression in the kidney of diabetic rats.
Osorio H; Bautista R; Rios A; Franco M; Arellano A; Vargas-Robles H; Romo E; Escalante B
J Nephrol; 2010; 23(5):541-6. PubMed ID: 20349407
[TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholic acid decreases sodium-glucose cotransporter (SGLT2) expression and oxidative stress in the kidney of diabetic rats.
Osorio H; Coronel I; Arellano A; Franco M; Escalante B; Bautista R
Diabetes Res Clin Pract; 2012 Aug; 97(2):276-82. PubMed ID: 22429686
[TBL] [Abstract][Full Text] [Related]
7. Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus.
Vallon V; Rose M; Gerasimova M; Satriano J; Platt KA; Koepsell H; Cunard R; Sharma K; Thomson SC; Rieg T
Am J Physiol Renal Physiol; 2013 Jan; 304(2):F156-67. PubMed ID: 23152292
[TBL] [Abstract][Full Text] [Related]
8. Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy?
Panchapakesan U; Pegg K; Gross S; Komala MG; Mudaliar H; Forbes J; Pollock C; Mather A
PLoS One; 2013; 8(2):e54442. PubMed ID: 23390498
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Nrf2 in Renal Proximal Tubular Cells Stimulates Sodium-Glucose Cotransporter 2 Expression and Exacerbates Dysglycemia and Kidney Injury in Diabetic Mice.
Zhao S; Lo CS; Miyata KN; Ghosh A; Zhao XP; Chenier I; Cailhier JF; Ethier J; Lattouf JB; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD
Diabetes; 2021 Jun; 70(6):1388-1403. PubMed ID: 33820760
[TBL] [Abstract][Full Text] [Related]
10. The generalized aminoaciduria seen in patients with hepatocyte nuclear factor-1alpha mutations is a feature of all patients with diabetes and is associated with glucosuria.
Bingham C; Ellard S; Nicholls AJ; Pennock CA; Allen J; James AJ; Satchell SC; Salzmann MB; Hattersley AT
Diabetes; 2001 Sep; 50(9):2047-52. PubMed ID: 11522670
[TBL] [Abstract][Full Text] [Related]
11. A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene.
Menzel R; Kaisaki PJ; Rjasanowski I; Heinke P; Kerner W; Menzel S
Diabet Med; 1998 Oct; 15(10):816-20. PubMed ID: 9796880
[TBL] [Abstract][Full Text] [Related]
12. Selective SGLT2 inhibition by tofogliflozin reduces renal glucose reabsorption under hyperglycemic but not under hypo- or euglycemic conditions in rats.
Nagata T; Fukazawa M; Honda K; Yata T; Kawai M; Yamane M; Murao N; Yamaguchi K; Kato M; Mitsui T; Suzuki Y; Ikeda S; Kawabe Y
Am J Physiol Endocrinol Metab; 2013 Feb; 304(4):E414-23. PubMed ID: 23249697
[TBL] [Abstract][Full Text] [Related]
13. TS-071 is a novel, potent and selective renal sodium-glucose cotransporter 2 (SGLT2) inhibitor with anti-hyperglycaemic activity.
Yamamoto K; Uchida S; Kitano K; Fukuhara N; Okumura-Kitajima L; Gunji E; Kozakai A; Tomoike H; Kojima N; Asami J; Toyoda H; Arai M; Takahashi T; Takahashi K
Br J Pharmacol; 2011 Sep; 164(1):181-91. PubMed ID: 21410690
[TBL] [Abstract][Full Text] [Related]
14. Decreased glibenclamide uptake in hepatocytes of hepatocyte nuclear factor-1alpha-deficient mice: a mechanism for hypersensitivity to sulfonylurea therapy in patients with maturity-onset diabetes of the young, type 3 (MODY3).
Boileau P; Wolfrum C; Shih DQ; Yang TA; Wolkoff AW; Stoffel M
Diabetes; 2002 Dec; 51 Suppl 3():S343-8. PubMed ID: 12475773
[TBL] [Abstract][Full Text] [Related]
15. Experimental type II diabetes and related models of impaired glucose metabolism differentially regulate glucose transporters at the proximal tubule brush border membrane.
Chichger H; Cleasby ME; Srai SK; Unwin RJ; Debnam ES; Marks J
Exp Physiol; 2016 Jun; 101(6):731-42. PubMed ID: 27164183
[TBL] [Abstract][Full Text] [Related]
16. SHR3824, a novel selective inhibitor of renal sodium glucose cotransporter 2, exhibits antidiabetic efficacy in rodent models.
Yan PK; Zhang LN; Feng Y; Qu H; Qin L; Zhang LS; Leng Y
Acta Pharmacol Sin; 2014 May; 35(5):613-24. PubMed ID: 24786232
[TBL] [Abstract][Full Text] [Related]
17. Functional defect of truncated hepatocyte nuclear factor-1alpha (G554fsX556) associated with maturity-onset diabetes of the young.
Kooptiwut S; Sujjitjoon J; Plengvidhya N; Boonyasrisawat W; Chongjaroen N; Jungtrakoon P; Semprasert N; Furuta H; Nanjo K; Banchuin N; Yenchitsomanus PT
Biochem Biophys Res Commun; 2009 May; 383(1):68-72. PubMed ID: 19336222
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of human organic anion transporter 1 by B-cell CLL/lymphoma 6.
Wegner W; Burckhardt G; Henjakovic M
Am J Physiol Renal Physiol; 2014 Dec; 307(11):F1283-91. PubMed ID: 25234312
[TBL] [Abstract][Full Text] [Related]
19. Functional analyses of the mutation nt-128 T→G in the hepatocyte nuclear factor-1α promoter region in Chinese diabetes pedigrees.
Fang Q; Chen S; Wang Y; Jiang S; Zhang R; Hu C; Wang C; Liu F; Xiang K; Jia W
Diabet Med; 2012 Nov; 29(11):1456-64. PubMed ID: 22413961
[TBL] [Abstract][Full Text] [Related]
20. Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1alpha and -1beta mutations.
Pearson ER; Badman MK; Lockwood CR; Clark PM; Ellard S; Bingham C; Hattersley AT
Diabetes Care; 2004 May; 27(5):1102-7. PubMed ID: 15111528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
